NuSirt Biopharma
Latest round
- Series C
Last raised
- May 2015
Total raised
- $2.7M
Investors
- 4
About NuSirt Biopharma
Based in the US, NuSirt develops a technology platform with the goal of enabling the use of natural compounds to create synergy with known pharmaceuticals to prevent and treat chronic diseases resulting from over-nutrition and aging.
Who invested in NuSirt Biopharma
4 investors across 2 rounds
See all investors in NuSirt Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NuSirt Biopharma
Who invested in NuSirt Biopharma?
NuSirt Biopharma has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NuSirt Biopharma raised?
NuSirt Biopharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NuSirt Biopharma last raise money?
NuSirt Biopharma's most recent round on record is a Series C, in May 2015.
What does NuSirt Biopharma do?
Based in the US, NuSirt develops a technology platform with the goal of enabling the use of natural compounds to create synergy with known pharmaceuticals to prevent and treat chronic diseases resulting from over-nutrition and aging.
Where is NuSirt Biopharma headquartered?
NuSirt Biopharma is headquartered in Nashville, US.
Which VCs invest in companies like NuSirt Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at NuSirt Biopharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like NuSirt Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.